EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countries
On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…
-
-
Pfizer submitted Emergency Use Authorization for novel COVID-19 oral antiviral candidate
On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…
-
Pfizer and MPP announced agreement for COVID-19 oral antiviral treatment candidate to expand access in low- and middle-income countries
On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…
-
Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and older
On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…
-
Oxford vaccine reached two billion dose milestone
On Nov. 15, 2021, AstraZeneca reported that 2 billion doses of the COVID-19 vaccine had been released for…
-
Long-term study of children with COVID-19 began
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
-
Novavax announced submission of Biologics License Application in South Korea for approval of NVX-CoV2373
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
-
Innovation Pharmaceuticals conducted full data analysis of phase 2 brilacidin COVID-19 trial results to support inclusion in Government-sponsored trials
On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
-
Lincoln Children’s Zoo announced the deaths of three snow leopards due to COVID-19
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
-
Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
-
Innovation Pharmaceuticals announced topline results from phase 2 clinical trial of brilacidin for COVID-19
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyﾒs Phase 2 clinical trial of Brilacidin…
-
Zipline, Pfizer and BioNTech paved way for automated, on-demand delivery of first mRNA COVID-19 vaccines in Ghana
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
-
CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease
On Nov. 11, 2021, Roche announced that the European Medicines Agencyﾒs (EMA) Committee for Medicinal Products for Human…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
Global progress against measles threatened amidst COVID-19 pandemic
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…
-
Meridian Bioscience received FDA Emergency Use Authorization for Revogeneﾮ SARS-CoV-2 molecular assay
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneﾮ SARS-CoV-2 assay was granted Emergency Use Authorization by…
-
Biden Administration invested $650 million in rapid diagnostic testing into increase access to tests
On Nov. 10, 2021, the Biden-Harris Administration announced that it was increasing access to COVID-19 testing for Americans…
-
Politicization and COVID-19 vaccine resistance in the U.S. widened during pandemic
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
-
INOVIO received FDA authorization to proceed with INNOVATE phase 3 segment for COVID-19 vaccine candidate
On Nov. 9, 2021, Inovio Pharma announced that the U.S. Food and Drug Administration (FDA) provided authorization to…
-
Moderna filed to expand the conditional Marketing Authorization for COVID-19 vaccine in the EU to include children ages 6-11 years
On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…
-
Amyris announced JV partnership with ImmunityBio for next generation COVID-19 RNA vaccine
On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio…
-
Phase 3 analyses showed that a single dose of REGEN-COV provides long-term protection against COVID-19
On Nov. 8, 2021, Regeneron announced that the European Commission had approved the casirivimab and imdevimab antibody cocktail,…
-
FDA authorized additional indication for BinaxNOW COVID-19 over-the-counter antigen test
On Nov. 8, 2021, The U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for…
-
Ronapreve approved for additional indication as preventive treatment of symptomatic COVID-19 in Japan
On Nov. 5, 2021, Chugai Pharmaceutical, announced that it had obtained approval from the Ministry of Health, Labour…
-
Pfizer’s COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis
On Nov. 5, 2021, Pfizer announced it was investigational novel COVID-19 oral antiviral candidate, PAXLOVID, significantly reduced hospitalization…
-
Oxford University researchers uncovered gene that doubles risk of death from COVID-19
On Nov. 5, 2021, scientists at Oxford University announced they had identified the gene responsible for doubling the…
-
The FDA issued an emergency use authorization for the iHealth COVID-19 Antigen Rapid Test
On Nov. 5, 2021, the U.S. Food and Drug Administration The FDA issued an emergency use authorization (EUA)…
-
COVID-19 | Nanotechnology | Vaccine | WHO
Novavax filed COVID-19 vaccine for Emergency Use listing with World Health Organization
On Nov. 4, 2021, Novavax announced the completion of its rolling submission to the World Health Organization (WHO)…
-
WHO issued emergency use listing for eighth COVID-19 vaccine
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXINﾮ (developed…
-
Database lock completed for Innovation Pharmaceuticalsﾒ phase 2 clinical trial of brilacidin for COVID-19
On Nov. 3, 2021, Innovation Pharma announced that the Company had received confirmation that hard lock of the…
-
INOVIO further expanded INNOVATE phase 3 trial for COVID-19 DNA vaccine candidate INO-4800 in India
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
